ReviewTherapeutic advances in gastroenterology2015

The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).

Yang Won Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.